The Program Committee of the AUA has accepted the Theralase®'s abstract titled: ' Interim Analysis of Light-Activated TLD-1433 in a Phase II Clinical Study of BCG-Unresponsive Non-Muscle Invasive ...
Pfizer Inc. (NYSE: PFE) will present the latest results from its leading genitourinary (GU) portfolio at the American Society ...
Emily Willis, a former adult film star, has been left permanently disabled after a stay at Summit Malibu rehab center. Her ...
Don't lose out on precious sleep due to multiple nightly trips to the bathroom. Here are simple lifestyle changes that can ...
TORONTO, ON / ACCESS Newswire / January 27, 2025 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the resear ...
AI-powered planning and robotic precision revolutionize treatment, preserving continence and sexual functionNew York, NY, Jan ...
Debate over labeling certain cancers as 'benign' or 'premalignant' instead of 'cancer' due to stigma and fear. Experts weigh in on potential impact ...
A review into arrangements put in place to support the suspension of emergency general surgery at the South West Acute ...
Marketplace reveals the growing number of vet clinics being bought up by international corporations across the country and ...
Lili Reinhart revealed that her health challenges began four years ago, following repeated Covid-19 infection during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback